Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-650-8 | CAS number: 123-77-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 13 April 1998 - 05 May 1998
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- The study was conducted in complaince with GLP, however no official test guideline was quoted. The methodology employed is essentially compatible with OECD test guideline 403, however as no justification was given for why the maximum possible airborne concentration of test substance was so much lower than the concentration for a limit test, the data cannot be considered reliable without restrictions.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1988
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- yes
- Remarks:
- : no justification was given for why the maximum possible airborne concentration of test substance was so much lower than the concentration for a limit test, the data cannot be considered reliable without restrictions.
- GLP compliance:
- yes
- Remarks:
- The study report contains a statement of GLP compliance signed by the Study Director and a statement of Quality Assurance, however no certificate of GLP compliance issued by an independant authority was included.
- Test type:
- fixed concentration procedure
- Limit test:
- no
Test material
- Reference substance name:
- C,C'-azodi(formamide)
- EC Number:
- 204-650-8
- EC Name:
- C,C'-azodi(formamide)
- Cas Number:
- 123-77-3
- Molecular formula:
- C2H4N4O2
- IUPAC Name:
- diazene-1,2-dicarboxamide
- Details on test material:
- - Name of test material (as cited in study report): Unifoam AZ SO-NL
- Physical state: Yellow powder
- Analytical purity: 100%
- Purity test date: Not reported.
- Lot/batch No.: Not reported.
- Expiration date of the lot/batch: Not reported.
- Stability under test conditions: Stable.
- Storage condition of test material: Stored in the dark at room temperature.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River UK Limited, Manston Road, Margate, Kent, England.
- Age at study initiation: 6 weeks (males) and 8 weeks (female) old.
- Weight at study initiation: Approximately 200 g at study initiation.
- Fasting period before study: None reported.
- Housing: 5 rats of like sex per cage housed in polypropylene cages with wire mesh tops and floors.
- Diet (e.g. ad libitum): Free access to a measured excess amount of food (Labsure LAD 1).
- Water (e.g. ad libitum): Free access to tap water.
- Acclimation period: At least 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 to 22°C.
- Humidity (%): Mean humidity = 50%.
- Air changes (per hr): Not reported.
- Photoperiod (hrs dark / hrs light): Not reported.
IN-LIFE DATES: From: 21 April 1988 (Date of dosing / exposure) To: 05 May 1998
Administration / exposure
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Perspex chamber with square cross-section and pyramidal top
- Exposure chamber volume: Approximately 120 Litres
- Method of holding animals in test chamber: Rats were held in stainless steel mesh partitioned to provide 10 individual animal compartments.
- Source and rate of air:Clean, dry compressed air; source not specified.
- Method of conditioning air: Not reported.
- System of generating particulates/aerosols: Wright dust generator connected to a glass elutriation column to reduce the amount of non-respirable particulate in the aerosol.
- Method of particle size determination: Andersen mini-sampler
- Treatment of exhaust air: Not specified
- Temperature, humidity, pressure in air chamber: Temperature and humidity were recorded, but not included in the report.
TEST ATMOSPHERE
- Brief description of analytical method used: Gravimetric analysis of air samples drawn through glass fibre filters.
- Samples taken from breathing zone: yes
VEHICLE
- Composition of vehicle (if applicable): No vehicle used.
TEST ATMOSPHERE (if not tabulated)
- Particle size distribution: Refer to table in "Any other information".
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): Not calculated. - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- Gravimetric analysis only.
- Duration of exposure:
- 4 h
- Concentrations:
- Mean concentration by analysis = 0.521 mg/L.
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observed for clinical signs continuously throughout exposure period and then twice daily during the observation period. Bodyweight measured daily.
- Necropsy of survivors performed: yes
- Other examinations performed: food consumption and lung weights.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 0.52 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- No rats died during the study.
- Clinical signs:
- other: Partial closing of the eyes and yellow discolouration of the fur was seen in rats exposed to UNIFOAN AZ SO-NL . Restless behaviour was seen in a proportion of the rats during the first 30 minutes of exposure to the test substance. Test substance residue
- Body weight:
- There were no effects on bodyweight following exposure to the test substance.
- Gross pathology:
- There were no macroscopic abnormalities in the rats exposed to the test substance and no abnormalities in the control rats.
- Other findings:
- - Organ weights: The lung weight to bodyweight ratio was determined for all rats. The ratio was considered to be within normal limits for all rats.
- Histopathology: There were no histological findings that could be attributable to exposure to the test substance.
Applicant's summary and conclusion
- Conclusions:
- The 4-hour LC50 was estimated to be in excess of 0.52 mg/L of air. This was the highest airborne concentration that could be produced using the procedures employed.
- Executive summary:
An acute toxicity study was conducted to assess the acute toxicity of the test substance UNIFOAM AZ SO-NL by inhalation exposure (HLS 1988, OCI 43/881087). The study was conducted in compliance with GLP.
Five male and five female rats were exposed by whole body exposure to an atmosphere containing the test material as an airborne dust for an exposure period of four hours. A concurrent control group was exposed in a similar fashion to untreated air. Following the exposure process, animals were observed for 14 days, sacrificed, then a necroscopic examination performed.
There were no deaths during the study. Test substance residues were seen on the fur of most of the exposed rats for 3 days following exposure; all rats were normal by day 7 of the observation period. Body weight gains and the ratio of lung weight to bodyweight were unaffected by exposure to the test substance, and no macroscopic or microscopic abnormalities were seen during pathology. Analysis of the test atmosphere determined that the mean atmospheric concentration of the test substance during the exposure period was 0.52 mg/L.
The 4-hour LC50 was estimated to be in excess of 0.52 mg/L of air. This was the highest airborne concentration that could be produced using the procedures employed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.